Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Runo

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Turkish Journal of Nephrology|January 12, 2024
Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive reviewKrista L Lentine, Deborah J Levine, James R Runo, et al.
Transplantation|April 3, 2020
Long-term Outcomes and Survival in Moderate-severe Portopulmonary Hypertension After Liver TransplantCorey J Sadd, Fauzia Osman, Zhanhai Li, et al.
Pulmonary Circulation|May 4, 2022
Development of a PET/MRI exercise stress test for determining cardiac glucose dependence in pulmonary arterial hypertensionGregory P Barton, Philip A Corrado, Christopher J Francois, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2002
Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor IIJames R Runo, Cindy L Vnencak-Jones, Melissa Prince, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Heart (British Cardiac Society)|August 28, 2016
Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertensionAlessandro Bellofiore, Eric Dinges, Robert Naeije, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2026
Newly diagnosed pulmonary arterial hypertension following liver transplantation: Insights from a multicenter case seriesHilary M DuBrock, Divya Verma, Noah C Schoenberg, et al.
Transplantation|April 16, 2021
Incidence, Clinical Correlates, and Outcomes of Pulmonary Hypertension After Kidney Transplantation: Analysis of Linked US Registry and Medicare Billing ClaimsKrista L Lentine, Ngan N Lam, Yasar Caliskan, et al.
Annals of the American Thoracic Society|May 29, 2026
Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryBreanne E McCarthy, Rui Feng, Roberto Bernardo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Turkish Journal of Nephrology|January 12, 2024
Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive reviewKrista L Lentine, Deborah J Levine, James R Runo, et al.
Transplantation|April 3, 2020
Long-term Outcomes and Survival in Moderate-severe Portopulmonary Hypertension After Liver TransplantCorey J Sadd, Fauzia Osman, Zhanhai Li, et al.
Pulmonary Circulation|May 4, 2022
Development of a PET/MRI exercise stress test for determining cardiac glucose dependence in pulmonary arterial hypertensionGregory P Barton, Philip A Corrado, Christopher J Francois, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2002
Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor IIJames R Runo, Cindy L Vnencak-Jones, Melissa Prince, et al.
Transplantation Direct|February 12, 2025
The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) ExceptionsKathryn T Del Valle, Dana Kay, Michael J Krowka, et al.
Transplantation Direct|November 18, 2020
Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm HgHilary M DuBrock, James R Runo, Corey J Sadd, et al.
Heart (British Cardiac Society)|August 28, 2016
Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertensionAlessandro Bellofiore, Eric Dinges, Robert Naeije, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2026
Newly diagnosed pulmonary arterial hypertension following liver transplantation: Insights from a multicenter case seriesHilary M DuBrock, Divya Verma, Noah C Schoenberg, et al.
Transplantation|April 16, 2021
Incidence, Clinical Correlates, and Outcomes of Pulmonary Hypertension After Kidney Transplantation: Analysis of Linked US Registry and Medicare Billing ClaimsKrista L Lentine, Ngan N Lam, Yasar Caliskan, et al.
Annals of the American Thoracic Society|May 29, 2026
Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryBreanne E McCarthy, Rui Feng, Roberto Bernardo, et al.
Pageof 3